Showing results (191-200 of 263) with videos related to
Sort By:
Pageof 27
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2009
Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cellsShingo Hatakeyama, Kazuhiro Sugihara, Jun Nakayama, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 26, 2015
Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4Daiki Ogawara, Minoru Fukuda, Shiro Ueno, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 4, 2004
High-risk populations for nasal carriage of methicillin-resistant Staphylococcus aureusMinoru Fukuda, Hironori Tanaka, Yoshifumi Kajiwara, et al.Cancer Chemotherapy and Pharmacology|September 15, 2004
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancerMinoru Fukuda, Mikio Oka, Hiroshi Soda, et al.International Journal of Oncology|March 27, 2012
MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasisYuichiro Suzuki, Mihoko Sutoh, Shingo Hatakeyama, et al.Clinical Lung Cancer|January 24, 2012
Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancerHiroshi Takatani, Yoichi Nakamura, Seiji Nagashima, et al.Japanese Journal of Clinical Oncology|May 22, 2016
Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701Junichi Soh, Norihito Okumura, Masao Nakata, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2017
Surface LAMP-2 Is an Endocytic Receptor That Diverts Antigen Internalized by Human Dendritic Cells into Highly Immunogenic ExosomesDario Armando Leone, Andrea Peschel, Markus Brown, et al.Thoracic Cancer|July 23, 2022
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 studyMinoru Fukuda, Masafumi Yamaguchi, Takuya Yamazaki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Randomized phase II trial of irinotecan with paclitaxel or gemcitabine for non-small cell lung cancer: association of UGT1A1*6 and UGT1A1*27 with severe neutropeniaYoichi Nakamura, Hiroshi Soda, Mikio Oka, et al.Pageof 27